$8.64
-0.64-6.9%
Last update: Nov 4, 4:00 PM
Benitec Biopharma Inc
BNTCNASDAQ
Benitec Biopharma (BNTC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.26 | $-0.27 | $-0.23 | $-0.33 |
| Actual | $-0.26 | $-0.24 | $-0.26 | $-0.22 |
| Surprise | 0.00% | +11.1% | -13.0% | +33.3% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q1 '27E | Q2 '27E | Q3 '27E | Q4 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.29 | $-0.30 | $-0.34 | $-0.34 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Sep 14, 2026 | $-0.26 | $-0.26 | 0.00 % |
| Q3 | May 14, 2026 | $-0.24 | $-0.27 | 11.1 % |
| Q2 | Feb 12, 2026 | $-0.26 | $-0.23 | -13.0 % |
| Q1 | Nov 14, 2025 | $-0.22 | $-0.33 | 33.3 % |
